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Abstract
Extended-spectrum b-lactamase (ESBL) -producing Enterobacteriaceae have been notiﬁable according to the Swedish Communicable
Disease Act since 2007. A major increase in the number of cases has been observed, with 2099 cases in 2007 and 7225 cases in 2012. The
majority of the isolates are Escherichia coli. Additionally, Swedish data on the prevalence of ESBL-producing invasive isolates of E. coli are
available through EARS-Net, and through biannual point prevalence studies, where molecular characterization of isolates from the entire
country is carried out. This paper describes major trends in the Swedish epidemiology of ESBL-producing E. coli in the period 2007–2012.
Isolates from the point prevalence studies were subjected to antimicrobial susceptibility testing, ESBL genotyping, pulsed-ﬁeld gel
electrophoresis, multi-locus sequence typing and phylogenetic grouping with PCR. The distribution of sequence types, resistance genes and
susceptibility levels were all stable over the three study periods. The dominating resistance gene conferring ESBL was blaCTX-M-15, found in
54–58% of the isolates. ST131 represented 34–38% of the isolates. Other major sequence types were ST38, ST69, ST405, ST617 and ST648,
each representing 2–6% of the isolates. Phylogenetic group B2 was the most common, and was observed in 41–47% of the isolates.
However, among ST131 isolates the B2 phylogenetic group represented 90–98% of the isolates. The most important epidemiological
difference seen over time was that the median age of infected women decreased from 62 to 52 years (p <0.0001) and infected men from 67
to 64 years. A potential explanation might be the shift towards a higher proportion of community-acquired infections in individuals lacking
comorbidities.
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Abstract
The European Committee on Antimicrobial Susceptibility Testing (EUCAST) began harmonizing clinical breakpoints in Europe 2002. In
2009, work to develop a disc diffusion method began and the ﬁrst disc diffusion breakpoints calibrated to EUCAST clinical MIC breakpoints
were published in December 2009. In this study we validated EUCAST clinical zone diameter breakpoints against the International Standard
Organization (ISO) reference broth microdilution. A collection of 544 isolates (238 Gram-negative and 306 Gram-positive) were tested
against a panel of antimicrobial agents. Antimicrobial susceptibility testing was performed with broth microdilution as described by ISO and
disc diffusion in accordance with EUCAST methodology. Inhibition zone diameters and MIC values were interpreted and categorized (S, I
and R) according to EUCAST clinical breakpoint table version 2.0. Categorical agreement (CA) as well as minor (mD), major (MD) and very
major (VMD) discrepancies were determined. There was in general good correlation between susceptibility test results obtained with disc
diffusion and broth microdilution. Overall CA was 97.3% for all combinations of organisms and antimicrobial agents (n = 5231) and the
overall discrepancy rates were 110 (2.1%) mD, 24 (0.5%) MD and 7 (0.1%) VMD. The overall CA for Gram-positive and Gram-negative
organisms were 98.7% (2346 tests) and 96.2% (2942 tests), respectively. Seven VMD were observed, ﬁve for Gram-positive organisms
(coagulase negative staphylococci (n = 2) and Staphylococcus aureus (n = 3)) and two for Gram-negative organisms (Pseudomonas aeruginosa).
Minor discrepancies were mainly observed in Gram-negatives and were related to different antimicrobial agents and species.
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Abstract
The role of ﬁtness in transmission of drug-resistant strains has been explored in previous studies; but has not been established for F15/
LAM4/KZN strains, which were responsible for the extensively drug-resistant tuberculosis (XDR-TB) outbreak in Tugela Ferry, South
Africa. The biological ﬁtness of 15 clinical strains representing the F15/LAM4/KZN, Beijing, F11 and F28 families was determined by growth,
viability and competition assays and correlated with DNA sequencing of eight genes associated with drug resistance and putative
compensatory mechanisms. Similar growth rates were observed among susceptible, multidrug-resistant (MDR) and XDR strains of the KZN
and F28 genotypes. In contrast, Beijing and F11 MDR strains demonstrated signiﬁcantly reduced ﬁtness. Resistant strains exhibited
heterogeneous ﬁtness proﬁles in competition with different susceptible strains, suggesting strain dependence. In addition, co-culture growth
rates were consistently higher than independent growth rates in 13/14 competition pairs. All 14 drug-resistant strains retained viability, at a
low CFU/mL, when paired with susceptible strains. The persistence of such resistant strains could consequently support the acquisition of
additional drug-resistance-conferring mutations and/or the evolution of compensatory mechanisms. Frequently occurring mutations were
detected in KZN and F28 resistant strains whereas, the Beijing MDR strain harboured a less common katG mutation and the F11 MDR
strain had no katG mutation. Contrary to drug-resistant Beijing and F11 strains, the successful transmission of KZN strains, particularly
during the outbreak, may be attributed to the presence of drug-resistance-conferring mutations associated with little or no associated
ﬁtness costs. Ampliﬁed growth in co-culture may be suggestive of in vivo trans-complementation.
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